Depressive-Type Schizoaffective Disorder in a Young Adult Woman: Challenges in Diagnosis and Management, A Case Report

Authors

  • Muhammad Akmal Ghani Universitas Lampung
  • Tendry Septa Lampung Provincial Mental Hospital
  • Risti Graharti Medical Faculty Universitas Lampung

DOI:

https://doi.org/10.53089/medula.v16i3.1936

Keywords:

Skizoafektif, Diagnosis, Penatalaksanaan

Abstract

Depressive-type schizoaffective disorder (F25.1) is a psychiatric disorder characterized by the coexistence of psychotic symptoms typical of schizophrenia and prominent depressive symptoms within the same episode of illness. This disorder is thought to involve dysregulation of multiple neurotransmitter systems, particularly dopamine and serotonin, which contribute to the simultaneous manifestation of psychotic and affective symptoms. Establishing the diagnosis remains challenging due to its overlapping clinical features with schizophrenia and major depressive disorder with psychotic features. This case report describes a 26-year-old woman who presented to the Psychiatric Outpatient Clinic of Lampung Provincial Mental Hospital with complaints of talking to herself, auditory hallucinations consisting of voices commenting on her daily activities, insomnia, anxiety, feelings of worthlessness, and suicidal ideation that emerged during the course of her illness. The symptoms developed following psychosocial stressors, including family conflicts and economic difficulties. Mental status examination revealed hypotymic mood, blunted affect, circumstantial thought process, and a history of persistent auditory hallucinations, while cognitive function, orientation, and memory remained intact. Based on psychiatric assessment and the diagnostic criteria of the Indonesian Classification of Mental Disorders (PPDGJ-III), the patient was diagnosed with depressive-type schizoaffective disorder (F25.1). The diagnosis was established due to the simultaneous presence of schizophrenic and depressive symptoms within the same episode of illness. Differential diagnoses considered included paranoid schizophrenia and severe depressive episode with psychotic symptoms. The patient received pharmacological treatment consisting of risperidone, trihexyphenidyl, fluoxetine, lithium carbonate, and clobazam, accompanied by psychoeducation and supportive psychotherapy. Clinical improvement in psychotic symptoms and overall functioning was observed following treatment. Depressive-type schizoaffective disorder requires comprehensive clinical evaluation to distinguish it from other psychotic and affective disorders and necessitates a multidisciplinary approach combining pharmacological and psychosocial interventions to improve patient outcomes.

Author Biographies

Muhammad Akmal Ghani, Universitas Lampung

 

 

Tendry Septa, Lampung Provincial Mental Hospital

 

 

Risti Graharti, Medical Faculty Universitas Lampung

 

 

References

Departemen Kesehatan Republik Indonesia. Pedoman Penggolongan dan Diagnosis Gangguan Jiwa di Indonesia III (PPDGJ-III). Jakarta: Direktorat Jenderal Pelayanan Medik; 1993.

Menteri Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.02.02/MENKES/73/2015 tentang Pedoman Nasional Pelayanan Kedokteran Jiwa. Jakarta: Kementerian Kesehatan Republik Indonesia; 2015.

Pavlichenko A, Petrova N, Stolyarov A. The modern concept of schizoaffective disorder: a narrative review. Consortium Psychiatricum. 2024;5(3):42–55. doi:10.17816/CP15513.

Grace AA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and mood disorders. Nature Reviews Neuroscience. 2016;17(8):524–532.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.

Malaspina D, Owen MJ, Heckers S, Tandon R, Bustillo J, Schultz S, et al. Schizoaffective disorder in the DSM-5. Schizophrenia Research. 2013;150(1):21–25.

Pavlichenko A, Petrova N, Stolyarov A. The modern concept of schizoaffective disorder: a narrative review. Consortium Psychiatricum. 2024;5(3):42–55. doi:10.17816/CP15513.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.

Gaitonde SA, Avet C, de la Fuente Revenga M, et al. Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor. Molecular Psychiatry. 2024;29:2753–2764. doi:10.1038/s41380-024-02531-7.

McNeil SE, Gibbons JR, Cogburn M. Risperidone. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.

Sharp T, Collins H. Mechanisms of SSRI therapy and discontinuation. Current Topics in Behavioral Neurosciences. 2024;66:21–47. doi:10.1007/7854_2023_452.

Aouci R, Fontaine A, Vion A, Belz L, Levi G, Narboux-Nême N. The antidepressant action of fluoxetine involves the inhibition of Dlx5/6 in cortical GABAergic neurons through a TrkB-dependent pathway. Cells. 2024;13(15):1262. doi:10.3390/cells13151262.

Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian and New Zealand Journal of Psychiatry. 2021;55(1):7–117.

Humayun MJ, Samanta D, Carson RP. Clobazam. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.

Jensen HS, Nichol K, Lee D, Ebert B. Clobazam and its active metabolite N-desmethylclobazam display significantly greater affinities for α2- versus α1-GABAA-receptor complexes. PLoS One. 2014;9(2):e88456. doi:10.1371/journal.pone.0088456.

Bröms G, Cahling L, Berntsson A, Öhrmalm L. Psychoeducation and motivational interviewing to reduce relapses and increase patients' involvement in antipsychotic treatment: interventional study. BJPsych Bulletin. 2020;44(6):265–268. doi:10.1192/bjb.2020.28.

Choe K, Sung BJ, Kang Y, Yoo SY. Impact of psychoeducation on knowledge of and attitude toward medications in clients with schizophrenia and schizoaffective disorders. Perspectives in Psychiatric Care. 2016;52(2):113–119. doi:10.1111/ppc.12106.

Yanagida O, Uchino T, Uchimura N. The effects of psychoeducation on long-term inpatients with schizophrenia and schizoaffective disorder. Kurume Medical Journal. 2016;63(3–4):61–67.

Published

2026-06-13

How to Cite

Ghani, M. A., Septa, T. ., & Graharti, R. (2026). Depressive-Type Schizoaffective Disorder in a Young Adult Woman: Challenges in Diagnosis and Management, A Case Report. Medical Profession Journal of Lampung, 16(3), 152-158. https://doi.org/10.53089/medula.v16i3.1936

Issue

Section

Artikel

Most read articles by the same author(s)

<< < 1 2 3 4 > >>